Women taking the antidepressant paroxetine (brand name Seroxat) alongside tamoxifen for breast cancer were more likely to die from the disease than women on other antidepressants, a study found.
- Text size
Breast cancer death risk may be increased by antidepressant
A popular antidepressant could interfere with a breast cancer drug and lead to a greater risk of death, researchers have said.
